# The Safety and Effectiveness of (+)-Calanolide A in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

> **NCT00005120** · PHASE1 · UNKNOWN · sponsor: **Sarawak MediChem Pharmaceuticals** · enrollment: 16 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Calanolide A

## Key facts

- **NCT ID:** NCT00005120
- **Lead sponsor:** Sarawak MediChem Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2000-04
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 16 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005120, "The Safety and Effectiveness of (+)-Calanolide A in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00005120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*